{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:08:54Z","timestamp":1789214934947,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23H00552"],"award-info":[{"award-number":["JP23H00552"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["20fk0108543h0001"],"award-info":[{"award-number":["20fk0108543h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004206","name":"Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019670","name":"The Research Foundation for Microbial Diseases of the University of Osaka","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejps.2026.107619","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:13:05Z","timestamp":1784855585000},"page":"107619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of transduction properties and vaccine efficacy of a simian adenovirus type 25-based vector"],"prefix":"10.1016","volume":"225","author":[{"given":"Fuka","family":"Okumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sora","family":"Tokuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoi","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kahori","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-8178","authenticated-orcid":false,"given":"Hiroyuki","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107619_bib0020","doi-asserted-by":"crossref","unstructured":"Amarilla, A.A. et al., \u2018A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses\u2019, doi: 10.1038\/s41467-021-23779-5.","DOI":"10.1038\/s41467-021-23779-5"},{"issue":"7","key":"10.1016\/j.ejps.2026.107619_bib0010","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2005.08.101","article-title":"Development of nonhuman adenoviruses as vaccine vectors","volume":"24","author":"Bangari","year":"2006","journal-title":"Vaccine"},{"issue":"9653","key":"10.1016\/j.ejps.2026.107619_bib0009","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ejps.2026.107619_bib0008","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1086\/509258","article-title":"Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector","volume":"194","author":"Catanzaro","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejps.2026.107619_bib0017","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1186\/s12879-025-11410-7","article-title":"Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study","volume":"25","author":"Chemaitelly","year":"2025","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"10.1016\/j.ejps.2026.107619_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"issue":"27","key":"10.1016\/j.ejps.2026.107619_bib0005","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.vaccine.2009.03.080","article-title":"Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy","volume":"27","author":"Dudareva","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ejps.2026.107619_bib0022","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1128\/JVI.03162-12","article-title":"A novel bacterium-free method for generation of flavivirus infectious DNA by circular polymerase extension reaction allows accurate recapitulation of viral heterogeneity","volume":"87","author":"Edmonds","year":"2013","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.ejps.2026.107619_bib0031","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/vaccines7020040","article-title":"Safety and immunogenicity of a novel recombinant simian adenovirus ChAdOx2 as a vectored vaccine","volume":"7","author":"Folegatti","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"24","key":"10.1016\/j.ejps.2026.107619_bib0030","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/j.vaccine.2017.04.062","article-title":"A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice","volume":"35","author":"Fonseca","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ejps.2026.107619_bib0001","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/j.ymthe.2025.03.062","article-title":"Four decades of adenovirus gene transfer vectors: history and current use","volume":"33","author":"Hackett","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2026.107619_bib0032","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/B978-0-323-89821-8.00011-5","article-title":"Adenoviral vector construction II: bacterial systems","author":"Hemmi","year":"2025","journal-title":"Adenoviral Vectors Gene Ther."},{"issue":"23","key":"10.1016\/j.ejps.2026.107619_bib0013","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.1128\/JVI.78.23.13207-13215.2004","article-title":"Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5","volume":"78","author":"Holterman","year":"2004","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ejps.2026.107619_bib0023","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ymthe.2005.04.015","article-title":"Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors","volume":"12","author":"Kawabata","year":"2005","journal-title":"Mol. Ther."},{"issue":"627","key":"10.1016\/j.ejps.2026.107619_bib0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1996","article-title":"GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults","volume":"14","author":"Lanini","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.ejps.2026.107619_bib0044","article-title":"The protective effect of intranasal immunization with influenza virus recombinant adenovirus vaccine on mucosal and systemic immune response","volume":"130","author":"Lian","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2026.107619_bib0035","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/cbt.6.5.4004","article-title":"A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors","volume":"6","author":"Lin","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.ejps.2026.107619_bib0021","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-023-02025-y","article-title":"An optimized circular polymerase extension reaction-based method for functional analysis of SARS-CoV-2","volume":"20","author":"Liu","year":"2023","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.ejps.2026.107619_bib0026","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","article-title":"The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"Maizel","year":"1968","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ejps.2026.107619_bib0041","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymthe.2005.08.007","article-title":"Rapid Kupffer cell death after intravenous injection of adenovirus vectors","volume":"13","author":"Manickan","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2026.107619_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102282","article-title":"Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines","volume":"80","author":"Marquez-Martinez","year":"2023","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.ejps.2026.107619_bib0003","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendon\u00e7a","year":"2021","journal-title":"npj Vaccines"},{"issue":"20","key":"10.1016\/j.ejps.2026.107619_bib0018","first-page":"10133","article-title":"Efficacy of oxford-AstraZeneca (ChAdOx1 CoV-19) vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) cases, hospital admissions, type of variants, and deaths","volume":"27","author":"Meo","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.ejps.2026.107619_bib0024","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.gt.3301453","article-title":"A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob","volume":"8","author":"Mizuguchi","year":"2001","journal-title":"Gene Ther."},{"issue":"9","key":"10.1016\/j.ejps.2026.107619_bib0011","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/fvl-2016-0070","article-title":"Simian adenoviruses as vaccine vectors","volume":"11","author":"Morris","year":"2016","journal-title":"Future Virol."},{"issue":"2","key":"10.1016\/j.ejps.2026.107619_bib0004","first-page":"351","article-title":"Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States","volume":"11","author":"Nwanegbo","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.ejps.2026.107619_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124480","article-title":"Development of a novel adenovirus serotype 35 vector vaccine possessing an RGD peptide in the fiber knob and the E4 orf 4, 6, and 6\/7 regions of adenovirus serotype 5","volume":"662","author":"Onishi","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2026.107619_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26030-3","article-title":"Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus","volume":"12","author":"Ono","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ejps.2026.107619_bib0007","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1086\/587993","article-title":"Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag\/pol\/nef vaccine in healthy adults","volume":"46","author":"Priddy","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejps.2026.107619_bib0034","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/mthe.2001.0510","article-title":"Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector","volume":"5","author":"Reddy","year":"2002","journal-title":"Mol. Ther."},{"issue":"23","key":"10.1016\/j.ejps.2026.107619_bib0012","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2026.107619_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100432","article-title":"Adenovirus vector-based vaccine for infectious diseases","volume":"42","author":"Sakurai","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.ejps.2026.107619_bib0042","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/JVI.78.10.5368-5381.2004","article-title":"Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors","volume":"78","author":"Shayakhmetov","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2026.107619_bib0036","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.35","article-title":"Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome","volume":"1","author":"Shimizu","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"9","key":"10.1016\/j.ejps.2026.107619_bib0040","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1535-7163.MCT-10-0332","article-title":"Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy","volume":"9","author":"Short","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.ejps.2026.107619_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109014","article-title":"Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction","volume":"35","author":"Torii","year":"2021","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.ejps.2026.107619_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba8399","article-title":"A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques","volume":"6","author":"van Doremalen","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.ejps.2026.107619_bib0038","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ejps.2026.107619_bib0039","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3390\/v15061343","article-title":"Structural model for factor X inhibition of IgM and complement-mediated neutralization of adenovirus","volume":"15","author":"Wagner","year":"2023","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.ejps.2026.107619_bib0037","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcyt.2021.07.013","article-title":"Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy","volume":"23","author":"Wang","year":"2021","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.ejps.2026.107619_bib0029","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.addr.2004.12.010","article-title":"Approaches to improving the kinetics of adenovirus-delivered genes and gene products","volume":"57","author":"Xu","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ejps.2026.107619_bib0033","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/1348-0421.70016","article-title":"First versatile reverse genetics system for DNA viruses using circular polymerase extension reaction","volume":"69","author":"Yamamoto","year":"2025","journal-title":"Microbiol. Immunol."},{"issue":"6","key":"10.1016\/j.ejps.2026.107619_bib0006","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/jmv.23546","article-title":"Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults","volume":"85","author":"Zhang","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejps.2026.107619_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.09.004","article-title":"Construction and application of adenoviral vectors","volume":"34","author":"Zhang","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"}],"updated-by":[{"DOI":"10.1016\/j.ejps.2026.107658","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000}}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:40:57Z","timestamp":1787107257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"alternative-id":["S0928098726001934"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107619","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of transduction properties and vaccine efficacy of a simian adenovirus type 25-based vector","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107619"}}